Methods
This is a cross-sectional analytical and descriptive study that included
4324 pregnant women (4366 fetuses, included singleton and twin) referred
for FE from 2014 to 2022. The study was conducted at the Health world
hospitals and its outreach clinics and camps conducted for fetal
echocardiography. Almost 20% of cases were referred from outreach
clinic to our center. Detailed history was taken from all pregnant
mothers which included maternal age, obstetric history, gestational age
(GA), parity, abortions, still births, assisted reproductive technology
like In vitro fertilization(IVF)), and family history of CHD (maternal
CHD, other sibling with CHD), chromosomal or other congenital anomalies.
Prenatal risk factors were extracted
(maternal medical illnesses, infections, medications). Indications for
referral, anomaly scan report and fetal echocardiography diagnosis were
reported. Neonatal echocardiography was done for confirmation of FE
report, also the management plan and outcome of cardiac anomalies were
noted.